好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Radiomics Derived Brain Age Influences Patient Reported Outcomes After Acute Ischemic Stroke
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (11:45 AM-12:45 PM)
13-006

To investigate the relationship between radiomics derived brain age and Patient Reported Outcome Measures (PROMs) in acute ischemic stroke (AIS) patients.

Radiomics-derived brain age provides an objective, quantitative evaluation of brain health leveraging features of neuroimaging imperceptible to the human eye. Brain Age Gap (BAG) measures the difference between biological brain age and chronological brain age. A higher BAG has been associated with worse functional outcome as measured by the clinician-rated modified Rankin Scale (mRS). Considering the growing emphasis placed on patient reported outcomes, the association between BAG and PROMs remains to be evaluated.

Patients with AIS, T2-FLAIR MRI imaging, and PROMs from the COAST cohort (single center, 2017-2020) had BAG calculated using our previously developed radiomics-based pipeline. Outcomes were defined by global mental (TMental) and physical (TPhysical) scores based on responses to the PROMIS Global Health questionnaire (Range: 0-100). The association between poor outcome (T-score <50) and BAG was modeled using logistic regression adjusting for age, sex, and NIHSS score.

A total of 132 patients were analyzed (41% Female; median (IQR): Age 64 (57-71), NIHSS 2 (1-5), TMental 48.3 (43.5-53.3), TPhysical 47.7 (42.3-54.1)) with 75 and 76 patients having poor outcomes for TMental and TPhysical, respectively. Higher BAG was associated with worse TMental (aOR=1.71, 95%CI=1.17-2.58, p<0.01), but had no statistically significant impact on TPhysical scores (aOR=1.20, 95%CI=0.82-1.78, p=0.35).

Patients with a larger positive BAG —reflecting older appearing brains— reported worse mental, but not physical, health outcomes after AIS. Our results support the inclusion of brain age in clinical prognostication and future research into patient-centered outcomes after AIS.

Authors/Disclosures
Luca Angeleri, BS
PRESENTER
Mr. Angeleri has nothing to disclose.
Erik Lindgren, MD, PhD The institution of Dr. Lindgren has received research support from The Swedish Research Council. Dr. Lindgren has received research support from The Swedish Heart and Lung Foundation.
Martin Bretzner, MD, PhD Dr. Bretzner has nothing to disclose.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Natalia S. Rost, MD, MPH, FAAN, FAHA (Massachusetts General Hospital) Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Markus D. Schirmer, PhD (Massachusetts General Hospital) The institution of Dr. Schirmer has received research support from National Institute of Aging.